Crinetics Pharmaceuticals, Inc.
CRNX
35 insider filings · Latest: Sep 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2024 | Sep 10 4:11 PM | Betz Stephen F. | Proposed Sale | 1,035 | $51.50 | $53.3K | — | View → |
| Aug 26, 2024 | Aug 26 5:16 PM | Betz Stephen F. | Proposed Sale | 3,000 | $53.19 | $159.6K | — | View → |
← Previous
Page 3 of 3
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Feb 25 9:37 PM | Struthers Richard ScottDirector, President & CEO | Grant/Award | 228,000 | $43.79 | 228,000(D) | View → |
| Feb 23, 2026 | Feb 25 9:36 PM | Tobin SchilkeChief Financial Officer | Grant/Award | 50,000 | $43.79 | 50,000(D) | View → |
| Feb 23, 2026 | Feb 25 9:34 PM | Jeff E. KnightChief Operating Officer | Grant/Award | 55,000 | $43.79 | 55,000(D) | View → |
| Feb 23, 2026 | Feb 25 9:34 PM | Stephen F. BetzChief Scientific Officer | Grant/Award | 47,000 | $43.79 | 47,000(D) | View → |
| Feb 23, 2026 | Feb 25 9:32 PM | Isabel KalofonosChief Commercial Officer | Grant/Award | 55,000 | $43.79 | 55,000(D) | View → |
← Previous
Page 2 of 2